Comparison of COVID-19 infection, Acute Relapse, and Adverse Effects Following COVID-19 Vaccination Between Patients with Multiple Sclerosis and Other Neurological Disorders (PP-29)

Comparison of COVID-19 infection, Acute Relapse, and Adverse Effects Following COVID-19 Vaccination Between Patients with Multiple Sclerosis and Other Neurological Disorders (PP-29)

Background: Patients with neurological disorders have been vaccinated in response to the global COVID-19 pandemic. This study aimed to determine the factors contributing to COVID-19 infection and acute relapse and compare adverse effects following COVID-19 vaccination among patients with multiple sc...

Full description

Bibliographic Details
Main Authors:	Mohammad Yazdan Panah, Saeed Vaheb, Yousef Mokary, Elham Moases Ghaffary, Alireza Afshari-Safavi, Aysa Shaygannejad, Narges Ebrahimi, Vahid Shaygannejad, Omid Mirmosayyeb
Format:	Article
Language:	English
Published:	Iran University of Medical Sciences 2023-01-01
Series:	Neurology Letters
Subjects:	multiple sclerosis covid-19 sars-cov-2 vaccine other neurological disease adverse effect
Online Access:	https://www.neurologyletters.com/article_186578_d41d8cd98f00b204e9800998ecf8427e.pdf

Similar Items

Multiple sclerosis and personality traits: associations with depression and anxiety
by: Saeed Vaheb, et al.
Published: (2024-03-01)

Fingolimod‐induced bladder lymphoma in a patient with multiple sclerosis
by: Saeed Vaheb, et al.
Published: (2023-04-01)

Validity and reliability of the Persian version of Recce stigma scale in people with multiple sclerosis and its impact on quality of life
by: Mohammad Amin Habibi, et al.
Published: (2024-01-01)

Neurosarcoidosis in an adult man with a family history of MS: A case report
by: Omid Mirmosayyeb, et al.
Published: (2023-06-01)

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and COVID-19: A Systematic Review
by: Omid Mirmosayyeb, et al.
Published: (2023-03-01)

Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review (PP-25)
by: Fardin Nabizadeh, et al.
Published: (2023-01-01)

Comparing the hippocampal volumetric atrophy between demented and nondemented individuals with Parkinson's disease: A systematic review and meta‐analysis
by: Mohammad Yazdan Panah, et al.
Published: (2023-09-01)

Acute CNS demyelination in a subject with cerebellar ataxia following the first dose of COVID-19 vaccine; a case report
by: Omid Mirmosayyeb, et al.
Published: (2021-11-01)

Managing anxiety among multiple sclerosis patients during COVID-19 pandemic
by: Iman Adibi, et al.
Published: (2021-01-01)

Olfactory dysfunction in patients with multiple sclerosis; A systematic review and meta-analysis.
by: Omid Mirmosayyeb, et al.
Published: (2022-01-01)

Optical Coherence Tomography (OCT) Measurements and Disability in Multiple Sclerosis (MS): Protocol of Systematic Review
by: Omid Mirmosayyeb, et al.
Published: (2023-04-01)

Bell's palsy after Sputnik V COVID‐19 (Gam‐COVID‐Vac) vaccination
by: Omid Mirmosayyeb, et al.
Published: (2022-02-01)

Insights into the interplay between Epstein‐Barr virus (EBV) and multiple sclerosis (MS): A state‐of‐the‐art review and implications for vaccine development
by: Mahtab Mohammadzamani, et al.
Published: (2024-02-01)

MS care in novel coronavirus 19 pandemic
by: Neda Ramezani, et al.
Published: (2020-01-01)

Editorial: CNS autoimmune disorders and COVID-19
by: Omid Mirmosayyeb, et al.
Published: (2023-04-01)

Predictors of Catching COVID-19 Infection during Pandemic Stage in Patients with Multiple Sclerosis (MS)
by: Mahsa Ghajarzadeh, et al.
Published: (2022-01-01)

Persistent cognitive impairment as a rare manifestation of mild COVID-19 infection – A case series
by: Saba Naghavi, et al.
Published: (2022-03-01)

Comparison of Expression Levels of miR-29b-3p and miR-326 in T Helper-1 and T Helper-17 Cells Isolated from Responsive and Non-responsive Relapsing-remitting Multiple Sclerosis Patients Treated with Interferon-beta
by: Leila Karimi, et al.
Published: (2020-08-01)

Demographic and clinical characteristics of familial and sporadic multiple sclerosis patients
by: Shahrzad Mokhtari, et al.
Published: (2023-01-01)

Sociodemographic and Illness-Related Indicators to Predict the Status of Neuromyelitis Optica Spectrum Disorder (NMOSD) Five Years after Disease Onset
by: Dena Sadeghi-Bahmani, et al.
Published: (2022-01-01)

Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis
by: Omid Mirmosayyeb, et al.
Published: (2020-05-01)

Higher Disease and Pain Severity and Fatigue and Lower Balance Skills Are Associated with Higher Prevalence of Falling among Individuals with the Inflammatory Disease of Neuromyelitis Optica Spectrum Disorder (NMOSD)
by: Mahdi Barzegar, et al.
Published: (2020-11-01)

Psychometric properties of the persian version of the multiple sclerosis work difficulties questionnaire (MSWDQ) questionnaire
by: Omid Mirmosayyeb, et al.
Published: (2022-01-01)

Ischemic Strokes in a Young Woman With Manifestations of Multiple Sclerosis
by: Mohsen Janghorbani, et al.
Published: (2018-11-01)

Comparison of follicular T helper cells, monocytes, and T cells priming between newly diagnosed and rituximab-treated MS patients and healthy controls
by: Sheida Yahyazadeh, et al.
Published: (2022-01-01)

Abrupt bilateral blindness as a rare post-acute demyelinating consequence of COVID-19
by: Ali Motahharynia, et al.
Published: (2022-09-01)

Comparison Effect of Prescription Drugs on the Occurrence and the Number of Attacks in Patients with Multiple Sclerosis
by: Marjan Jamalian, et al.
Published: (2018-01-01)

Prevalence of seizure/epilepsy in patients with multiple sclerosis: A systematic review and meta-analysis
by: Omid Mirmosayyeb, et al.
Published: (2021-01-01)

<i>ADAR</i> Expression and Single Nucleotide Variants in Multiple Sclerosis Patients Affect the Response to Interferon Beta Therapy
by: Fakhr Fakhr, et al.
Published: (2023-09-01)

Can helicobacter pylori infection reduce the risk of Multiple sclerosis? A systematic review and meta-analysis
by: Fardin Nabizadeh, et al.
Published: (2023-07-01)

Clinical Outcome and Volumetric MRI Assessment of Brain and Cervical Spinal Cord Area in Secondary Progressive Multiple Sclerosis Patients Treated with Rituximab: one-year follow-up (ORP-08)
by: Yousef Mokary, et al.
Published: (2023-11-01)

Association Between Helicobacter Pylori Infection and Seronegative Neuromyelitis Optica Spectrum Disorder
by: Mahdi Barzegar, et al.
Published: (2023-01-01)

Assessment the Possible Association Between Neuromyelitis Optica and Cytomegalovirus as a Provocative Factor
by: Mahboubeh Jazini, et al.
Published: (2019-03-01)

Comparison of Psychological Difficulties in Patients with Migraine and Epilepsy Using PARADISE-24 Questionnaire
by: Mirmosayyeb O, et al.
Published: (2020-07-01)

The Role of Cobalamin on Interleukin 10, Osteopontin, and Related MicroRNAs in Multiple Sclerosis
by: Mohammad Sadegh Hesamian, et al.
Published: (2022-06-01)

Spinal cord MRI in multiple sclerosis; diagnostic, prognostic, and clinical value (ORP-55)
by: Vahid Shaygannejad
Published: (2023-01-01)

Association Between Sunlight Exposure and Vitamin D Intake and Multiple Sclerosis Disability and Progression
by: Emad Fayyazi, et al.
Published: (2018-08-01)

Patterns of attention deficit in relapsing and progressive phenotypes of multiple sclerosis
by: Farinaz Tabibian, et al.
Published: (2023-08-01)

Association between sun exposure, Vitamin D intake, serum Vitamin D level, and immunoglobulin G level in patients with neuromyelitis optica spectrum disorder
by: Vahid Shaygannejad, et al.
Published: (2018-01-01)

Oral SERD, a Novel Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer
by: Niraj Neupane, et al.
Published: (2024-01-01)